Prevention of corticosteroid-induced osteoporosis: Results of a patient survey

Arthritis and Rheumatism

Volumn 42, Issue 8, 1999, Pages 1736-1739

  Buckley, Lenore M ^a   Marquez, Mariella ^a   Feezor, Robert ^a   Ruffin, David M ^a   Benson, Linda L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; CALCIUM INTAKE; CORTICOSTEROID THERAPY; DENSITOMETRY; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DENSITOMETRY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0033495980     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199908)42:8<1736::AID-ANR24>3.0.CO;2-E     Document Type: Article

References (14)

1. Saag K, Koehnke R, Caldwell J, Brasington R, Burmeister LF, Zimmerman B, et al. Low dose long-term corticosteroid therapy in RA: an analysis of serious adverse events. Am J Med 1994;96:115-23.
2. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54: 810-6.
3. Buckley LM, Leib ES, Cartularo KM, Vacek PM, Cooper SM. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 1996;125:961-8.
4. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993;328:1747-52.
5. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
6. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998;339: 292-9.
7. Healey JH, Paget SA, Williams-Russo P, Szatrowskl TP, Schneider R, Spiers H, et al. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int 1996;58: 73-80.
8. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992;7:1063-9.
9. Hall GM, Daniels M, Doyle DV, Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994;37: 1499-505.
10. Ringe JD, Welzel D. Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol 1987;33:35-9.
11. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39: 1791-801.
12. Peat ID, Healy S, Reid DM, Ralston SH. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis 1995;54: 66-8.
13. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996;313:344-6.
14. Buckley LM, Marquez M, Hudson J, Downs R, Vacek P, Small R, et al. Variations in physicians' judgements about corticosteroid induced osteoporosis by physician specialty. J Rheumatol 1998;25: 2195-202.